globalrepmsia.com

Malaysia: Your Gateway to ASEAN Healthcare Growth

/
/
Malaysia: Your Gateway to ASEAN Healthcare Growth
your gateway to asean health

Malaysia: Your Gateway to ASEAN Healthcare Growth

Leveraging Malaysia as a Strategic Investment Platform for Regional Expansion, Innovation and Healthcare Excellence

Global Rep was honored to participate in the webinar organized by Informa Markets on 5 Aug 2026, where government representatives and industry leaders shared valuable insights on how Malaysia’s robust infrastructure, highly skilled workforce, and strong regional connectivity are enabling businesses to expand their presence and unlock new opportunities across one of the world’s fastest-growing healthcare markets.

Malaysia stands out as a prime destination for healthcare investment in ASEAN. With a robust healthcare market, strong infrastructure, and political stability, it offers both affordability and innovation. Its medical tourism sector continues to expand, supported by advanced facilities and the Malaysia Healthcare Travel Council (MHTC). Strategic initiatives like the World Health Expo Kuala Lumpur further connect investors to regional opportunities, making Malaysia a thriving hub for healthcare growth and partnerships.

Overview

The webinar discussed Malaysia’s strategic role in ASEAN healthcare growth. Mr. Abdul Halim Muhammad Shariff (Abdul Halim), Deputy Director of the Life Science and Lifestyle Section at the Malaysia External Trade Development Corporation (MATRADE), highlighted Malaysia’s healthcare ecosystem, including its $21.6 billion healthcare spending and 34.4 million population. Mr. Lokman Izam Abd Aziz (Lokman), Vice President of Marketing & Communications emphasized Malaysia’s medical tourism potential, noting a 101% revenue increase since 2019 and a $10,000 health screening costing under $800. Ms. Nisha Tamzamrat (Nisha), Source of Asia (SOA), showcased the World Health Expo Kuala Lumpur, expecting 450 exhibitors and 13,000 attendees in 2027. Ms. Rathanesh Ramasundram (Rathanesh), Head of Healthcare & Life Sciences, Frost & Sullivan, identified key investment themes: preventive healthcare, chronic disease management, elderly care, digital health, diagnostics, and medical tourism, predicting a 15% annual growth in healthcare travelers.

Abdul Halim highlighted Malaysia’s unique position in the ASEAN healthcare market, emphasizing its comprehensive healthcare ecosystem, including manufacturing and clinical research. He noted Malaysia’s high healthcare expenditure per capita, which supports investment in new technologies and treatments. Lokman discussed Malaysia’s attractiveness for healthcare business and medical travelers, citing its unique selling propositions and investment opportunities across various healthcare sectors. He also mentioned the role of Malaysia Healthcare Travel Council (MHTC) in facilitating processes for international patients and investors. The session concluded with a call for further engagement and partnerships within the ASEAN healthcare market.

Outline​

Abdul Halim Mohamed Shariff’s Presentation on Malaysia as a Strategic Investment Platform

  • Abdul Halim introduces MATRADE and its role in promoting Malaysian companies internationally.
  • Abdul Halim discusses the growth of the global healthcare industry, predicting a $11.3 trillion market by 2030.
  • He highlights the challenges faced by the global healthcare industry, including lifestyle changes, aging population, and technological gaps.
  • Abdul Halim emphasizes Malaysia’s strategic location and advantages, such as political stability and connectivity, making it a hub for the healthcare industry.
  • Abdul Halim explains Malaysia’s two-tier healthcare system: public and private, with the private sector driven by insurance and healthcare tourism.
  • He highlights the growth of private hospitals and the increasing demand for healthcare services in Malaysia.
  • Abdul Halim discusses the opportunities in the healthcare industry, including preventive lifestyle services and aged care living.
  • He mentions the government’s focus on developing the healthcare product-related manufacturing and reforming the healthcare services.

Lokman Izam Abd Aziz’s Presentation on Medical Tourism Excellence in Malaysia

  • Lokman introduces the Malaysia Healthcare Travel Council (MHTC) and its role in positioning Malaysia as a leading healthcare travel destination.
  • Lokman explains the patient journey in medical tourism and the importance of trust, partnerships, and capital in the industry.
  • He highlights the global growth of the medical tourism market and Malaysia’s strong growth in the sector.
  • Lokman discusses the multiplier effect of medical tourism on various industries and the importance of nurturing trust among patients.

Nisha Tamzamrat’s Presentation on Connecting to ASEAN Healthcare Business

  • Nisha introduces World Health Expo Kuala Lumpur (WHX Kuala Lumpur) and its role in connecting international business with opportunities across the ASEAN healthcare market.
  • She highlights the ASEAN market’s potential, with a combined healthcare expenditure of $270 billion in 2026.
  • Nisha discusses the advantages of Malaysia as a medical hub, including its strategic location, technology adoption, and competitive costs.
  • She outlines the features of WHX Kuala Lumpur, including exhibitions, conferences, and business matching platforms.

Rathanesh Ramasundram’s Presentation on Malaysia’s Private Healthcare Advantage

  • Rathanesh discusses Malaysia’s position as a platform for ASEAN healthcare growth, emphasizing its strong ecosystem and underlying economics.
  • He highlights the demographic changes in Malaysia, with the country expected to reach aged nation status by 2030.
  • Rathanesh explains the opportunities in the private healthcare sector, including preventive healthcare, chronic disease management, and elderly care.
  • He emphasizes the importance of investing in asset-light, recurring revenue models and moving beyond traditional hospital beds.

Malaysia’s Unique Healthcare Ecosystem

  • Abdul Halim Mohamed Shariff highlights that while Malaysia has a smaller population compared to Indonesia and the Philippines, it offers a unique proposition in the healthcare ecosystem.
  • Malaysia is established in healthcare services, manufacturing, and clinical research, with the latter led by Clinical Research Malaysia.
  • The country’s demographic profile attracts a significant number of clinical studies, enhancing its research capabilities.
  • Abdul Halim notes that Malaysia’s high healthcare expenditure per capita, though lower than Singapore and Brunei, indicates affordability for good healthcare services and new technologies.
  • Malaysia’s high healthcare expenditure supports the investment in new technologies and treatments, making it an attractive destination for healthcare investments.

Healthcare Expenditure and Investment Opportunities

  • Abdul Halim emphasizes that Malaysia’s high healthcare expenditure per capita complements the surrounding region, providing support through its healthcare services.
  • The ecosystem in Malaysia extends healthcare services to the region, supporting health tourism and the overall healthcare needs of the ASEAN region.
  • Mariyah invites Lokman Izam Abd Aziz to share his thoughts on what makes Malaysia an attractive destination for healthcare business and medical travelers.
  • Lokman Izam Abd Aziz approaches the question from two perspectives: the unique selling propositions of Malaysia and the investment opportunities for investors.
  • He highlights the importance of the overall ecosystem, from pre-patient care to post-patient care, and the role of MHC in easing and smoothing the process for investors.

Investment Opportunities and Business Pathways

  • Lokman Izam Abd Aziz discusses the role of MHC in working with agents from various countries to ensure proper documentation and medical records.
  • He mentions the need for translation services in different languages, which are available not only in Malaysia but also in the countries of origin.
  • The opportunities for investors in Malaysia depend on the nature of their business, such as medical device providers and hospitals.
  • Each pathway within the ecosystem offers unique propositions for investors, making Malaysia an attractive destination for various healthcare investments.

Your Trusted Partner for Medical Device Regulatory Affairs in Malaysia

Global Rep is committed to driving your business expansion into Malaysia’s dynamic healthcare market. As your local authorized representative, we support medical device registration in Malaysia and manage all post-market compliance activities, so you can concentrate fully on scaling your business. 

With our expertise and strategic solutions, entering Malaysia becomes not just easier, but smarter. Connect with Global Rep today to discover how we can accelerate your growth and unlock new opportunities.

Recent Posts

China Malaysia medical device regulatory bridge for market access

Your China–Malaysia Medical Device Regulatory...

For a Chinese medical device manufacturer planning to enter Malaysia,…
China NMPA vs Malaysia MDA medical device pre-market approval recognition

China NMPA vs Malaysia MDA...

Recognition of foreign pre-market approvals is a clear and growing…
Southeast Asian medical device markets and regulatory pathways

Which Southeast Asian Country Should...

For a medical device manufacturer planning to expand into Southeast…